Literature DB >> 8865032

Reversible oral-facial dyskinesia in a patient receiving ciprofloxacin hydrochloride.

P Pastor, E Moitinho, I Elizalde, I Cirera, E Tolosa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8865032     DOI： 10.1007/bf00900953

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  12 in total

1.  Acute psychoses associated with the use of ciprofloxacin and trimethoprim-sulfamethoxazole.

Authors:  J D McCue; J R Zandt
Journal:  Am J Med       Date:  1991-04       Impact factor: 4.965

2.  Phenytoin-induced hyperkinesia.

Authors:  K Lühdorf; M Lund
Journal:  Epilepsia       Date:  1977-09       Impact factor: 5.864

3.  Epileptogenic effect of antibiotic drugs.

Authors:  T O Grøndahl; I A Langmoen
Journal:  J Neurosurg       Date:  1993-06       Impact factor: 5.115

4.  Ciprofloxacin-induced complex partial status epilepticus manifesting as an acute confusional state.

Authors:  S H Isaacson; J Carr; A J Rowan
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

5.  [Choreoathetosis. Uncommon manifestation during chronic liver disease with portocaval shunt].

Authors:  D L Spitaleri; S Vitolo; A M Fasanaro; R Valiani
Journal:  Riv Neurol       Date:  1983 Sep-Oct

6.  Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: a randomized, double-blind trial.

Authors:  G Lindsay; H J Scorer; C M Carnegie
Journal:  J Antimicrob Chemother       Date:  1992-07       Impact factor: 5.790

7.  Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis.

Authors:  L M Gunne; J E Häggström; B Sjöquist
Journal:  Nature       Date:  1984 May 24-30       Impact factor: 49.962

8.  The substantia innominata complex and the peripeduncular nucleus in orofacial dyskinesia: a pharmacological and anatomical study in cats.

Authors:  W P Spooren; W H Mulders; J G Veening; A R Cools
Journal:  Neuroscience       Date:  1993-01       Impact factor: 3.590

9.  Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes.

Authors:  A Tsuji; H Sato; Y Kume; I Tamai; E Okezaki; O Nagata; H Kato
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

10.  Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy.

Authors:  G K Thaker; J A Nguyen; M E Strauss; R Jacobson; B A Kaup; C A Tamminga
Journal:  Am J Psychiatry       Date:  1990-04       Impact factor: 18.112
View more
  5 in total

Review 1.  Quinolones: review of psychiatric and neurological adverse reactions.

Authors:  Ana M Tomé; Augusto Filipe
Journal:  Drug Saf       Date:  2011-06-01       Impact factor: 5.606

Review 2.  Neurotoxic effects associated with antibiotic use: management considerations.

Authors:  Marie F Grill; Rama K Maganti
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

Review 3.  Movement disorders of the mouth: a review of the common phenomenologies.

Authors:  C M Ghadery; L V Kalia; B S Connolly
Journal:  J Neurol       Date:  2022-07-29       Impact factor: 6.682

4.  Ciprofloxacin-associated choreoathetosis in a haemodialysis patient.

Authors:  Ahad Abdalla; Shazrul Ramly; Peter Boers; Liam Casserly
Journal:  BMJ Case Rep       Date:  2013-04-18

5.  Reversible craniocervical dystonia associated with levofloxacin.

Authors:  Karlo J Lizarraga; Maria R Lopez; Carlos Singer
Journal:  J Clin Mov Disord       Date:  2015-05-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.